Silymarin for the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT02006498 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

99

Enrollment

OTHER

Sponsor class

Conditions

Non-alcoholic Fatty Liver Disease

Interventions

DRUG: Sillymarin
DRUG: Placebo

Sponsor

University of Malaya

Collaborators

[object Object]